摘要
目的探讨甲泼尼龙联合人血白蛋白治疗急性重症病毒性脑炎的疗效。方法回顾性分析2006年5月—2011年5月在我科住院治疗的急性重症病毒性脑炎患者共53例,将其按治疗方法分为两组:治疗组给予甲泼尼龙和人血白蛋白治疗;对照给予常规地塞米松治疗。治疗后比较两组的疗效、病死率及平均住院时间。结果治疗组疗效优于对照组,病死率低于对照组,平均住院时间短于对照组,差异有统计学意义(P<0.05)。结论甲泼尼龙联合人血白蛋白治疗急性重症病毒性脑炎可有效降低病死率,缩短病程,减少后遗症。
Objective To investigate the clinical effect of methylprednisolone combined with human albumine in treatment of acute sever viral encephalitis.Methods A retrospective analysis from May 2006 to May 2011 in our hospital treatment of acute severe viral encephalitis patients were 53 cases,the patients were divided into two groups： treatment group received prednisolone and methylprednisolone for the treatment of human albumin were given conventional treatment with dexamethasone.After treatment,the efficacy was compared between the two groups in mortality and hospitalization time.Results The efficacy of the treatment group was superior to the control group,the mortality rate is lower than that of the control group,the average hospitalization time was shorter than the control group,the difference was statistically significant（P 0.05）.Conclusion The study indicited that usage of dosage of methylprednisolone and human albumine can reduce mortality rates,shorten the average hospitalization,and lessen disability for acute sever viral encephalitis.
出处
《实用心脑肺血管病杂志》
2013年第7期83-84,共2页
Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词
脑炎
病毒性
甲泼尼龙
人血白蛋白
治疗结果
Encephalitis
viral
Methylprednisolone
Human albumine
Treatment outcome
